MedTrace Logo

Using an End-of-life Conversation Game to Engage Underserved Communities in Advance Care Planning

NCT03456921 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1122

Last updated 2019-11-04

No results posted yet for this study

Summary

This national project will provide an effective, evidence-based intervention for advance care planning (ACP) to 50 underserved US communities, those with poor access to healthcare systems due to economic, cultural or other barriers. The project will also examine 15 of the 50 communities to learn about the unique needs of African American communities in regards to ACP and to assess the intervention with this population. The team includes the Hospice Foundation of America and a university-based research team from Penn State Milton S. Hershey Medical Center.

Conditions

  • Advance Care Planning
  • Vulnerable Populations
  • Advance Directives
  • Terminal Illness

Interventions

OTHER

End-of-life conversation game called "Hello"

To play 'Hello', players are provided 32 open-ended questions in a prearranged order and an equal number of game chips. A player reads aloud the first question. Players then individually write down their answers, and take turns sharing answers with the group (players can opt to pass). Players control how long they share, what they share, and when they are ready to proceed to the next question. During the conversation, players may choose to acknowledge others for a particularly thoughtful, poignant, or even funny comment by giving them a chip. A simple pre-game coin flip determines whether the player with the most chips 'wins' the game ('heads'), or the player with the least amount of chips wins the game ('tails').

Sponsors & Collaborators

  • John and Wauna Harman Foundation

    collaborator UNKNOWN

  • Hospice Foundation of America

    collaborator UNKNOWN

  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • Lauren J Van Scoy · Penn State College of Medicine

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-28
Primary Completion
2019-09-15
Completion
2019-09-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03456921 on ClinicalTrials.gov